Dietary Ammonium Hydroxide Enhancement Modulates Renal Inflammatory and Apoptotic Signaling and Mitochondrial-Associated Pathways in High-Fat-Fed C3H/HeJ Mice
Abstract
1. Introduction
2. Materials and Methods
2.1. Animal Study and Experimental Diets
2.2. Quantitative Real-Time PCR (qRT-PCR)
2.3. Western Blot Analysis
2.4. Histological Analysis of Kidney Tissue
2.5. Statistical Analysis
3. Results
3.1. Dietary Ammonium Hydroxide Enhancement (AHE) Attenuates Renal Inflammatory Signaling
3.2. Renal Apoptosis-Related Protein Expression Is Modulated by AHE


3.3. AHE Modulates Renal Mitochondrial Dynamics and Associated Markers
3.4. Renal Ammonia Transporter Expression Is Increased by AHE
3.5. Long Term AHE Is Associated with Altered Renal Tubular Morphometric Parameters


4. Discussion
Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AHE | Ammonium hydroxide enhancement |
| A.U. | Arbitrary units |
| BCL2 | B-cell lymphoma 2 |
| BUN | Blood urea nitrogen |
| CC | Control casein diet |
| CCN | Control casein diet with ammonium hydroxide enhancement |
| CKD | Chronic kidney disease |
| DRP1 | Dynamin-related protein 1 |
| FDA | Food and Drug Administration |
| FIS1 | Mitochondrial fission protein 1 |
| H&E | Hematoxylin and eosin |
| HFB | High-fat beef diet |
| HFBN | High-fat beef diet with ammonium hydroxide enhancement |
| HFC | High-fat casein diet |
| HFCN | High-fat casein diet with ammonium hydroxide enhancement |
| IL-6 | Interleukin-6 |
| LSD | Least significant difference |
| MFN2 | Mitofusin 2 |
| NF-κB | Nuclear factor kappa B |
| OPA1 | Optic atrophy protein 1 |
| PGC1α | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| PINK1 | PTEN-induced kinase 1 |
| qPCR | Quantitative real-time polymerase chain reaction |
| RHBG | Rh family B glycoprotein |
| RHCG | Rh family C glycoprotein |
| SEM | Standard error of the mean |
| TFAM | Mitochondrial transcription factor A |
| TLR4 | Toll-like receptor 4 |
| TNFα | Tumor necrosis factor alpha |
| WB | Western blot |
References
- León-Román, J.; López-Martínez, M.; Esteves, A.; Ciudin, A.; Núñez-Delgado, S.; Álvarez, T.; Lecube, A.; Rico-Fontalvo, J.; Soler, M.J. Obesity-Related Kidney Disease: A Growing Threat to Renal Health. Int. J. Mol. Sci. 2025, 26, 6641. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Barr, B.; Gollahon, L. The Modification of Dietary Protein with Ammonium Hydroxide Enhancement Improves Longevity and Metabolic Outcomes in a Sex-Dependent Manner. Nutrients 2024, 16, 2787. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Xu, W.; Zhu, Y.; Wang, S.; Liu, J.; Li, H. From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease. Antioxidants 2024, 13, 1540. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wieërs, M.; Beynon-Cobb, B.; Visser, W.J.; Attaye, I. Dietary acid load in health and disease. Pflug. Arch. 2024, 476, 427–443. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- O’Rourke, R.W. Inflammation in obesity-related diseases. Surgery 2009, 145, 255–259. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shirsat, P.; Balachandran, M.; Chamarthi, V.S.; Sonavane, K. Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Impact, and Management Strategies. J. CardioRenal Med. 2025, 1, 4. [Google Scholar] [CrossRef] [Scilit]
- Imenez Silva, P.H.; Mohebbi, N. Kidney metabolism and acid-base control: Back to the basics. Pflug. Arch. 2022, 474, 919–934. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Naber, T.; Purohit, S. Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease. Nutrients 2021, 13, 3277. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rico-Fontalvo, J.; Raad-Sarabia, M.; Montejo Hernández, J.; Rodríguez Yánez, T.; Caparroso Ramos, L.R.; Parra Sánchez, P.; Ovalle Gomez, A.A.; Quintero, J.J.; Daza-Arnedo, R. Inflammatory and lipotoxicity mechanisms in obesity related CKD. Front. Nephrol. 2025, 5, 1684004. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Castro, B.B.A.; Reno, P.F.; Pereira, B.F.; Arriel, K.; Bonato, F.B.; Colugnati, F.A.B.; Cenedeze, M.A.; Saraiva-Camara, N.O.; Sanders-Pinheiro, H. Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity. J. Bras. Nefrol. 2024, 46, e20230148. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rebholz, C.M.; Coresh, J.; Grams, M.E.; Steffen, L.M.; Anderson, C.A.; Appel, L.J.; Crews, D.C. Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study. Am. J. Nephrol. 2015, 42, 427–435. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Scialla, J.J.; Anderson, C.A. Dietary acid load: A novel nutritional target in chronic kidney disease? Adv. Chronic Kidney Dis. 2013, 20, 141–149. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Williamson, M.; Moustaid-Moussa, N.; Gollahon, L. The Molecular Effects of Dietary Acid Load on Metabolic Disease (The Cellular PasaDoble: The Fast-Paced Dance of pH Regulation). Front. Mol. Med. 2021, 1, 777088. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Goraya, N.; Madias, N.E.; Simoni, J.; Kahlon, M.; Aksan, N.; Wesson, D.E. Randomized Trial of Dietary Acid Reduction and Acid-Base Status of Patients with CKD and Normal Estimated GFR. Kidney Int. Rep. 2025, 10, 355–374. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Barr, B.R.; Subramaniyan, I.; Li, L.; Levitt, D.E.; Gollahon, L.S. Ammonium Hydroxide Enhancement of Dietary Protein in High-Fat Diets Modulates Liver Metabolism Signaling in a Sex- and Age-Dependent Manner in C3H/HeJ Mice. Int. J. Mol. Sci. 2025, 27, 403. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Boren, C.; Barr, B.; Mubtasim, N.; Gollahon, L. Adipocytokine Protein Expression from Visceral Fat Differs Significantly Based on Diet, Sex, and Age in C3H/HeJ Mice Fed Long-Term, High-Fat Diets, ± Ammonium-Hydroxide-Supplemented Dietary Protein. Curr. Issues Mol. Biol. 2025, 47, 218. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Garrison, E.C.; Brown, A.M.V.; Salazar, M.M.; Barr, B.; Moustaid-Moussa, N.; Gollahon, L.S. Microbiome Taxonomic and Functional Differences in C3H/HeJ Mice Fed a Long-Term High-Fat Diet with Beef Protein ± Ammonium Hydroxide Supplementation. Nutrients 2024, 16, 1613. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Montoya-Torres, B.; Kaur, A.; Barr, B.; Garrison, E.; Brashears, M.M.; Brown, A.M.V.; Gollahon, L.S. Microbiome Taxonomic and Functional Differences in C3H/HeJ Mice Fed a Long-Term High-Fat Diet with Casein Protein ± Ammonium Hydroxide Supplementation. Dietetics 2026, 5, 13. [Google Scholar] [CrossRef] [Scilit]
- Mubtasim, N.; Barr, B.; Boren, C.; Gollahon, L. Effects of Aging on Secreted Adipocytokines in Visceral Fat of Female C3H/HeJ Mice Consuming a Long-Term High-Fat Diet. Dietetics 2024, 3, 191–213. [Google Scholar] [CrossRef] [Scilit]
- Menikdiwela, K.R.; Guimarães, J.P.T.; Scoggin, S.; Gollahon, L.S.; Moustaid-Moussa, N. Dietary pH Enhancement Improves Metabolic Outcomes in Diet-Induced Obese Male and Female Mice: Effects of Beef vs. Casein Proteins. Nutrients 2022, 14, 2583. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Roth, E. Method for Modifying pH Within Meat Products. U.S. Patent No. 7,022,361, 4 April 2006. [Google Scholar]
- Clementi, A.; Virzì, G.M.; Sorbello, M.; Marzano, N.; Monciino, P.; Cabrera-Aguilar, J.S.; Battaglia, G.G.; Ronco, C.; Zanella, M. Hepato-Renal Crosstalk in Acute and Chronic Disease: From Shared Pathways to Therapeutic Targets. Biomedicines 2025, 13, 1618. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Capalbo, O.; Giuliani, S.; Ferrero-Fernández, A.; Casciato, P.; Musso, C.G. Kidney-liver pathophysiological crosstalk: Its characteristics and importance. Int. Urol. Nephrol. 2019, 51, 2203–2207. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Weiner, I.D.; Verlander, J.W. Renal ammonia metabolism and transport. Compr. Physiol. 2013, 3, 201–220. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bhargava, P.; Schnellmann, R.G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 2017, 13, 629–646. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Forbes, J.M.; Thorburn, D.R. Mitochondrial dysfunction in diabetic kidney disease. Nat. Rev. Nephrol. 2018, 14, 291–312. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Arabi, T.; Shafqat, A.; Sabbah, B.N.; Ashraf, N.; Shah, H.; Abdulkader, H.; Razak, A.; Sabbah, A.N.; Arabi, Z. Obesity-related kidney disease: Beyond hypertension and insulin-resistance. Front. Endocrinol. 2022, 13, 1095211. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kadatane, S.P.; Satariano, M.; Massey, M.; Mongan, K.; Raina, R. The Role of Inflammation in CKD. Cells 2023, 12, 1581. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Liu, T.; Zhang, L.; Joo, D.; Sun, S.-C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2017, 2, 17023. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alhamar, G.; Razafiarison, J.; Alzaid, F.; Al-Mulla, F.; Ahmad, R. Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases. Obes. Rev. 2026, 27, e70107. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Grande, M.T.; Pérez-Barriocanal, F.; López-Novoa, J.M. Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy. J. Inflamm. 2010, 7, 19. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Petruliene, K.; Zilinskiene, A.; Vaiciuniene, R.; Vaiciunas, K.; Bumblyte, I.A.; Dalinkeviciene, E. Obesity and Its Clinical Implications in End-Stage Kidney Disease. Medicina 2026, 62, 211. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Andres-Hernando, A.; Lanaspa, M.A.; Kuwabara, M.; Orlicky, D.J.; Cicerchi, C.; Bales, E.; Garcia, G.E.; Roncal-Jimenez, C.A.; Sato, Y.; Johnson, R.J. Obesity causes renal mitochondrial dysfunction and energy imbalance and accelerates chronic kidney disease in mice. Am. J. Physiol.-Ren. Physiol. 2019, 317, F941–F948. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Galvan, D.L.; Green, N.H.; Danesh, F.R. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 2017, 92, 1051–1057. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rovira-Llopis, S.; Bañuls, C.; Diaz-Morales, N.; Hernandez-Mijares, A.; Rocha, M.; Victor, V.M. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications. Redox Biol. 2017, 11, 637–645. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sun, Y.; Ge, X.; Li, X.; He, J.; Wei, X.; Du, J.; Sun, J.; Li, X.; Xun, Z.; Liu, W.; et al. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis. 2020, 11, 914. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tang, C.; Cai, J.; Yin, X.M.; Weinberg, J.M.; Venkatachalam, M.A.; Dong, Z. Mitochondrial quality control in kidney injury and repair. Nat. Rev. Nephrol. 2021, 17, 299–318. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shao, N.; Wang, J.; Liu, J.; Zhang, J.; Zhang, B.; Sun, X.; Liu, X. Mitochondrial Dynamics in Diabetic Kidney Disease: Underlying Mechanisms and Novel Therapeutics. Int. J. Mol. Sci. 2026, 27, 2429. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fontecha-Barriuso, M.; Martin-Sanchez, D.; Martinez-Moreno, J.M.; Monsalve, M.; Ramos, A.M.; Sanchez-Niño, M.D.; Ruiz-Ortega, M.; Ortiz, A.; Sanz, A.B. The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules 2020, 10, 347. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, X.; Agborbesong, E.; Li, X. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential. Int. J. Mol. Sci. 2021, 22, 11253. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Xie, J.H.; Li, Y.Y.; Jin, J. The essential functions of mitochondrial dynamics in immune cells. Cell. Mol. Immunol. 2020, 17, 712–721. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bhatia, D.; Capili, A.; Choi, M.E. Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches. Kidney Res. Clin. Pr. 2020, 39, 244–258. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Weiner, I.D.; Verlander, J.W. Role of NH3 and NH4+ transporters in renal acid-base transport. Am. J. Physiol. Ren. Physiol. 2011, 300, F11–F23. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Weiner, I.D.; Verlander, J.W. Ammonia Transporters and Their Role in Acid-Base Balance. Physiol. Rev. 2017, 97, 465–494. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Harris, A.N.; Skankar, M.; Melanmed, M.; Batlle, D. An Update on Kidney Ammonium Transport Along the Nephron. Adv. Kidney Dis. Health 2023, 30, 189–196. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Barr, B.; Gollahon, L. The Effects of Obesity on Sex, Aging, and Cancer Development in a Longitudinal Study of High-Fat-Diet-Fed C3H/HeJ Mice. Obesities 2024, 4, 314–328. [Google Scholar] [CrossRef] [Scilit]
- Rao, X.; Huang, X.; Zhou, Z.; Lin, X. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat. Bioinforma Biomath. 2013, 3, 71–85. [Google Scholar] [PubMed]
- Furth, S.L.; Colhoun, H.M.; Kanbay, M.; Kukla, A.; Lim, L.-L.; MacLaughlin, H.L.; Navaneethan, S.D.; Shroff, R.; Stenvinkel, P.; Cheung, M.; et al. The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2026, 109, 442–464. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Prasad, R.; Jha, R.K.; Keerti, A. Chronic Kidney Disease: Its Relationship with Obesity. Cureus 2022, 14, e30535. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Papier, K.; Hartman, L.; Tong, T.Y.N.; Key, T.J.; Knuppel, A. Higher Meat Intake Is Associated with Higher Inflammatory Markers, Mostly Due to Adiposity: Results from UK Biobank. J. Nutr. 2022, 152, 183–189. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kounatidis, D.C.; Evangelopoulos, A.; Dimitriou, K.; Vallianou, N.G. Ultra-Processed Foods and Chronic Kidney Disease: Is Inflammaging the Missing Link? Biomolecules 2026, 16, 660. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Owens, E.P.; Vesey, D.A.; Kassianos, A.J.; Healy, H.; Hoy, W.E.; Gobe, G.C. Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease. Transl. Androl. Urol. 2019, 8, S175–S183. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Goraya, N.; Wesson, D.E. Pathophysiology of Diet-Induced Acid Stress. Int. J. Mol. Sci. 2024, 25, 2336. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010, 49, 1603–1616. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Priante, G.; Gianesello, L.; Ceol, M.; Del Prete, D.; Anglani, F. Cell Death in the Kidney. Int. J. Mol. Sci. 2019, 20, 3598. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Burlaka, I.; Nilsson, L.M.; Scott, L.; Holtbäck, U.; Eklöf, A.-C.; Fogo, A.B.; Brismar, H.; Aperia, A. Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease. Kidney Int. 2016, 90, 135–148. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gooz, M. Mitochondria—An old-new link in the progression of renal disease. Ren. Fail. 2025, 47, 2602986. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, Y.; Lv, L.; Zhou, Z.; Zhang, H.; Li, Q.; Yang, S.; Wen, Y.; Wang, Q.; Feng, J.; Lu, W.; et al. Piezo1 facilitates the initiation and progression of renal fibrosis by mediating cell apoptosis and mitochondrial dysfunction. Ren. Fail. 2024, 46, 2415519. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Silva Ramos, E.; Larsson, N.G.; Mourier, A. Bioenergetic roles of mitochondrial fusion. Biochim. Biophys. Acta 2016, 1857, 1277–1283. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Doblado, L.; Lueck, C.; Rey, C.; Samhan-Arias, A.K.; Prieto, I.; Stacchiotti, A.; Monsalve, M. Mitophagy in Human Diseases. Int. J. Mol. Sci. 2021, 22, 3903. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Saxena, S.; Mathur, A.; Kakkar, P. Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy. J. Cell. Physiol. 2019, 234, 19223–19236. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ishihara, M.; Urushido, M.; Hamada, K.; Matsumoto, T.; Shimamura, Y.; Ogata, K.; Inoue, K.; Taniguchi, Y.; Horino, T.; Fujieda, M.; et al. Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am. J. Physiol. Ren. Physiol. 2013, 305, F495–F509. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Duan, P.; Tan, J.; Miao, Y.; Zhang, Q. PINK1/Parkin-Mediated Mitophagy Plays a Protective Role in Albumin Overload-Induced Renal Tubular Cell Injury. Front. Biosci. 2022, 27, 184. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wesson, D.E.; Buysse, J.M.; Bushinsky, D.A. Mechanisms of Metabolic Acidosis–Induced Kidney Injury in Chronic Kidney Disease. J. Am. Soc. Nephrol. 2020, 31, 469–482. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kim, H.-Y. Renal Handling of Ammonium and Acid Base Regulation. Electrolyte Blood Press. 2009, 7, 9–13. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lee, H.W.; Verlander, J.W.; Bishop, J.M.; Nelson, R.D.; Handlogten, M.E.; Weiner, I.D. Effect of intercalated cell-specific Rh C glycoprotein deletion on basal and metabolic acidosis-stimulated renal ammonia excretion. Am. J. Physiol. Ren. Physiol. 2010, 299, F369–F379. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Banerjee, T.; Crews, D.C.; Wesson, D.E.; Tilea, A.M.; Saran, R.; Ríos-Burrows, N.; Williams, D.E.; Powe, N.R. High Dietary Acid Load Predicts ESRD among Adults with CKD. J. Am. Soc. Nephrol. 2015, 26, 1693–1700. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hall, M.E.; do Carmo, J.M.; da Silva, A.A.; Juncos, L.A.; Wang, Z.; Hall, J.E. Obesity, hypertension, and chronic kidney disease. Int. J. Nephrol. Renov. Dis. 2014, 7, 75–88. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mashayekhi, M.; Zuckerman, J.E.; Koubar, S.H.; Wu, J.; Qing, J.; Abdipour, A.; Lerma, E.; Peters, W.; Norouzi, S. Obesity-related glomerulopathy, A growing kidney burden in the obesity pandemic. Clin. Exp. Nephrol. 2026, 30, 363–372. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Declèves, A.E.; Sharma, K. Obesity and kidney disease: Differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr. Opin. Nephrol. Hypertens. 2015, 24, 28–36. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chevalier, R.L. The proximal tubule is the primary target of injury and progression of kidney disease: Role of the glomerulotubular junction. Am. J. Physiol. Ren. Physiol. 2016, 311, F145–F161. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bourgeois, S.; Houillier, P. State of knowledge on ammonia handling by the kidney. Pflüg. Arch.-Eur. J. Physiol. 2024, 476, 517–531. [Google Scholar] [CrossRef] [Scilit] [PubMed]





| Gene | Forward | Reverse |
|---|---|---|
| TLR4 | 5′-TTG CAT CTG GCT GGG ACT CTG-3′ | 5′-TTC AGG GGG TTG AAG CTC AGA T-3′ |
| NFkB | 5′-CCT CCA CCC CGA CGT ATT GC-3′ | 5′-GCC AAG GCC TGG TTT GAG AT-3′ |
| TNFα | 5′-GAA CTC CAG GCG GTG TCT GT-3′ | 5′-CTG AGT GTG AGG GTC TGG GC-3′ |
| IL1β | 5′-ATG TCT TGC CCG TGG AGC TT-3′ | 5′-ATG GGT CAG ACA GCA CGA GG-3′ |
| RHBG | 5′-GCCGTGTATCAGCTCTTCGGAA-3′ | 5′-AACCTGGTCCTCGAAGCATTGG-3′ |
| RHCG | 5′-CAGTTCCTTCCACGGAGATGCC-3′ | 5′-AAGCGTGGCATTCTGGATGTGC-3′ |
| B-actin | 5′-ACA ACC TTC TTG CAG CTC CTC C-3′ | 5′-TGA CCC ATA CCC ACC ATC ACA-3′ |
| Primary Antibody | Species | Dilution | Vendor | Secondary Antibody | Dilution | Vendor |
|---|---|---|---|---|---|---|
| NFkB | Rabbit polyclonal | 1:1000 | Cell Signaling Technology, Inc., Danvers, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| TNFα | Rabbit polyclonal | 1:1000 | Abcam, Cambridge, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| TLR4 | Mouse Monoclonal | 1:1000 | Novus Biological, Littleton, CO, USA | Rabbit anti mouse HRP | 1:10,000 | Abcam, Cambridge, MA, USA |
| IL6 | Mouse Monoclonal | 1:1000 | Invitrogen, Carlsbad, CA, USA | Rabbit anti mouse HRP | 1:10,000 | Abcam, Cambridge, MA, USA |
| Caspase 3 | Rabbit polyclonal | 1:1000 | Bioss Antibodies, Woburn, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| P53 | Rabbit polyclonal | 1:1000 | Abcam, Cambridge, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| BCL2 | Rabbit Monoclonal | 1:1000 | Cell Signaling Technology, Inc., Danvers, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| MFN2 | Rabbit polyclonal | 1:1000 | Cell Signaling Technology, Inc., Danvers, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| Opa1 | Rabbit polyclonal | 1:1000 | Novus Biological, Littleton, CO, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| TFAM | Rabbit polyclonal | 1:1000 | Novus Biological, Littleton, CO, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| FIS 1 | Rabbit polyclonal | 1:1000 | Protein Tech Group, Inc., Chicago, IL, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| Drp 1 | Rabbit polyclonal | 1:1000 | Novus Biological, Littleton, CO, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| Pink 1 | Rabbit polyclonal | 1:500 | Novus Biological, Littleton, CO, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| Parkin 1 | Mouse polyclonal | 1:500 | Novus Biological, Littleton, CO, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| RHBG | Rabbit polyclonal | 1:1000 | Thermo Fisher Scientific, Inc., Waltham, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| RHCG | Rabbit polyclonal | 1:1000 | Bioss Antibodies, Woburn, MA, USA | Goat anti-rabbit HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
| B-actin | Mouse Monoclonal | 1:2000 | Millipore Sigma (Burlington, MA, USA) | Horse anti-mouse HRP | 1:2000 | Cell Signaling Technology, Inc., Danvers, MA, USA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Deshmukh, H.; Schacherer, C.; Yeom, K.; Rivera, A.; Gollahon, L. Dietary Ammonium Hydroxide Enhancement Modulates Renal Inflammatory and Apoptotic Signaling and Mitochondrial-Associated Pathways in High-Fat-Fed C3H/HeJ Mice. Dietetics 2026, 5, 54. https://doi.org/10.3390/dietetics5040054
Deshmukh H, Schacherer C, Yeom K, Rivera A, Gollahon L. Dietary Ammonium Hydroxide Enhancement Modulates Renal Inflammatory and Apoptotic Signaling and Mitochondrial-Associated Pathways in High-Fat-Fed C3H/HeJ Mice. Dietetics. 2026; 5(4):54. https://doi.org/10.3390/dietetics5040054
Chicago/Turabian StyleDeshmukh, Hemalata, Camille Schacherer, Kyunghoon Yeom, Alaina Rivera, and Lauren Gollahon. 2026. "Dietary Ammonium Hydroxide Enhancement Modulates Renal Inflammatory and Apoptotic Signaling and Mitochondrial-Associated Pathways in High-Fat-Fed C3H/HeJ Mice" Dietetics 5, no. 4: 54. https://doi.org/10.3390/dietetics5040054
APA StyleDeshmukh, H., Schacherer, C., Yeom, K., Rivera, A., & Gollahon, L. (2026). Dietary Ammonium Hydroxide Enhancement Modulates Renal Inflammatory and Apoptotic Signaling and Mitochondrial-Associated Pathways in High-Fat-Fed C3H/HeJ Mice. Dietetics, 5(4), 54. https://doi.org/10.3390/dietetics5040054

